Incidence of clinically significant responses to zolpidem among patients with disorders of consciousness: A preliminary placebo controlled trial

American Journal of Physical Medicine and Rehabilitation

Volumn 88, Issue 5, 2009, Pages 410-418

  Whyte, John ^a   Myers, Robin ^a  

^a MOSS REHABILITATION RESEARCH INSTITUTE   (United States)

Author keywords

Brain injuries; Vegetative state; Zolpidem

Indexed keywords

AMANTADINE; BACLOFEN; BROMOCRIPTINE MESILATE; CARBIDOPA; CLONAZEPAM; CLONIDINE; DIAZEPAM; ETIRACETAM; GABAPENTIN; LEVODOPA; METHYLPHENIDATE; PHENYTOIN; PLACEBO; SCOPOLAMINE; TIZANIDINE; TRAZODONE; ZOLPIDEM; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; PYRIDINE DERIVATIVE;

ADULT; ARTICLE; BRAIN INJURY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONSCIOUSNESS DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEEDING APPARATUS; FEMALE; FREQUENCY ANALYSIS; HUMAN; MALE; MINIMALLY CONSCIOUS STATE; PERSISTENT VEGETATIVE STATE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SINGLE DRUG DOSE; TREATMENT RESPONSE; CONVALESCENCE; GLASGOW COMA SCALE; MIDDLE AGED; MULTICENTER STUDY; PILOT STUDY;

ADULT; BRAIN INJURIES; DOUBLE-BLIND METHOD; FEMALE; GABA AGONISTS; GLASGOW COMA SCALE; HUMANS; MALE; MIDDLE AGED; PERSISTENT VEGETATIVE STATE; PILOT PROJECTS; PYRIDINES; RECOVERY OF FUNCTION; YOUNG ADULT;

EID: 68049143015     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/PHM.0b013e3181a0e3a0     Document Type: Article

References (14)

1. Giacino J, Ashwal S, Childs N, et al: The minimally conscious state: Definition and diagnostic criteria. Neurology 2002;58:349-353 (Pubitemid 34150906)
2. The Multi-Society Task Force Report on PVS: Medical aspects of the persistent vegetative state. N Engl J Med 1994;330:1499 -508, 1572-1579 (Pubitemid 124005046)
3. Giacino J, Whyte J: The vegetative and minimally conscious states: Current knowledge and remaining questions. J Head Trauma Rehabil 2005;20:30-50 (Pubitemid 40250684)
4. Jarry C, Fontenas JP, Jonville-Bera AP, et al: Beneficial effect of zolpidem for dementia. Ann Pharmacother 2002;36:1808 (Pubitemid 35265624)
5. Cohen L, Chaaban B, Habert MO: Transient improvement of aphasia with zolpidem. N Engl J Med 2004;350:949-950
6. Brefel-Courbon C, Payoux P, Fabierine O, et al: Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy. Ann Neurol 2007;62:102-105 (Pubitemid 47240911)
7. Clauss RP, Nel WH: Effect of zolpidem on brain injury and diaschisis as detected by 99mTc HMPAO brain SPECT in humans. Arzneimittelforschung 2004;54: 641-646
8. Clauss R, Nel H: Evidence for zolpidem efficacy in brain damage. SA Fam Pract 2005;47:49-50 (Pubitemid 40823036)
9. Clauss R, Nel W: Drug-induced arousal from the permanent vegetative state. NeuroRehabilitation 2006;21:23-28 (Pubitemid 43754180)
10. Singh R, McDonald C, Dawson K, et al: Zolpidem in a minimally conscious state. Brain Inj 2008;22: 103-106
11. Berlin I, Warot D, Hergueta T, et al: Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects. J Clin Psychopharmacol 1992;13:100-106 (Pubitemid 23087225)
12. Clauss R, Dormehl I, Kilian E, et al: Cerebral blood perfusion after treatment with zolpidem and flumazenil in the baboon. Arzneimittelforschung 2002;52: 740-744 (Pubitemid 35222022)
13. Rappaport M, Hall KM, Hopkins K, et al: Disability Rating Scale for severe head trauma: Coma to community. Arch Phys Med Rehabil 1982;63:118-123 (Pubitemid 12190593)
14. Giacino JT, Kalmar K, Whyte J: The JFK Coma Recovery Scale-Revised: Measurement characteristics and diagnostic utility. Arch Phys Med Rehabil 2004;85:2020-2029 (Pubitemid 39593531)